
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Summary for Tradename: A-HYDROCORT
|
| |||||||||
Clinical Trials for: A-HYDROCORTContribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC) Status: Recruiting Condition: Obesity Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration Status: Recruiting Condition: Major Depressive Disorder; Anxiety Disorders Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis Status: Active, not recruiting Condition: Atopic Dermatitis Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency Status: Completed Condition: Primary Adrenal Insufficiency Once-Daily Oral Modified-Release Hydrocortisone in Patients With Adrenal Insufficiency Status: Completed Condition: Adrenal Insufficiency Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure Status: Not yet recruiting Condition: Addison Disease Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT) Status: Active, not recruiting Condition: Adrenal Insufficiency Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis Status: Withdrawn Condition: Sepsis; Adrenal Insufficiency Glucocorticoid Treatment in Addison's Disease Status: Completed Condition: Addison's Disease Continuous Subcutaneous Hydrocortisone Infusion In Addison`s Disease and Type 1 Diabetes Status: Not yet recruiting Condition: Addison Disease; Type 1 Diabetes Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | A-HYDROCORT | hydrocortisone sodium succinate | INJECTABLE; INJECTION | 040666 | Apr 6, 2006 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hospira | A-HYDROCORT | hydrocortisone sodium succinate | INJECTABLE; INJECTION | 085929 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hospira | A-HYDROCORT | hydrocortisone sodium succinate | INJECTABLE; INJECTION | 085930 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hospira | A-HYDROCORT | hydrocortisone sodium succinate | INJECTABLE; INJECTION | 085931 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc